Artificial Intelligence (AI) in Non-Small Cell Lung Cancer and Immunotherapy: A Review of the Emerging Uses and Current Challenges

Lung cancer remains the leading cause of cancer-related mortality worldwide despite major therapeutic advances, including immune checkpoint inhibitors (ICIs). Although a subset of patients with advanced non-small cell lung cancer (NSCLC) experiences durable long-term responses, currently available predictive biomarkers, including programmed death ligand-1 (PD-L1) expression, have limited ability to reliably distinguish responders from non-responders. Artificial intelligence (AI) and machine learning (ML) have emerged as powerful approaches for extracting clinically meaningful patterns from complex, high-dimensional datasets spanning pathology, liquid biopsy, imaging, and integrated multimodal data. This narrative review examines current applications of AI in NSCLC immunotherapy across these complementary data modalities and evaluates the evidence supporting their clinical translation. Particular attention is given to the methodological limitations of existing studies and to the emerging shift from single-modality biomarkers toward dynamic and multimodal prediction. Although AI-based approaches show potential to complement established biomarkers, limitations in validation, generalizability, and prospective evidence currently restrict their clinical implementation.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-13
DOI
https://doi.org/10.3390/ijms272210196
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Artificial Intelligence (AI) in Non-Small Cell Lung Cancer and Immunotherapy: A Review of the Emerging Uses and Current Challenges

Sahar Nangoli, Matthew Lee
4 links
International Journal of Molecular Sciences
Cancer Immunotherapy and Biomarkers
article

Artificial Intelligence (AI) in Non-Small Cell Lung Cancer and Immunotherapy: A Review of the Emerging Uses and Current Challenges

Sahar Nangoli, Matthew Lee
article en

Abstract

Lung cancer remains the leading cause of cancer-related mortality worldwide despite major therapeutic advances, including immune checkpoint inhibitors (ICIs). Although a subset of patients with advanced non-small cell lung cancer (NSCLC) experiences durable long-term responses, currently available predictive biomarkers, including programmed death ligand-1 (PD-L1) expression, have limited ability to reliably distinguish responders from non-responders. Artificial intelligence (AI) and machine learning (ML) have emerged as powerful approaches for extracting clinically meaningful patterns from complex, high-dimensional datasets spanning pathology, liquid biopsy, imaging, and integrated multimodal data. This narrative review examines current applications of AI in NSCLC immunotherapy across these complementary data modalities and evaluates the evidence supporting their clinical translation. Particular attention is given to the methodological limitations of existing studies and to the emerging shift from single-modality biomarkers toward dynamic and multimodal prediction. Although AI-based approaches show potential to complement established biomarkers, limitations in validation, generalizability, and prospective evidence currently restrict their clinical implementation.

International Journal of Molecular SciencesVol. 27(22)
City Of Hope National Medical Center (US), City of Hope (US), Kaiser Permanente Bernard J. Tyson School of Medicine (US)
Good health and well-being
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon